UCLTF £1m investment into Quell Therapeutics is part of a £35m Series A round led by Syncona
Odin Vision is to scale up its pioneering cancer detection technology thanks to an investment round led by the UCLTF, alongside London Co-Investment Fund and AI seed and grant funding from InnovateUK, the NHS and the UK Space Agency and European Space Agency.
Astroscreen uses machine learning and disinformation analysts to detect social media manipulation.
The funding is led by AlbionVC, with participation from all existing investors including Downing Ventures and Unilever Ventures. It will now enable the provider to continue successfully disrupting the customer service industry as it further develops its SmartCrowd™ platform.
The investment will support Mirada’s development of artificial intelligence (AI) based software for increasing the speed and accuracy of cancer treatment planning applications.
AVORA has already built an impressive client base, including Telefonica, OMD, NPR, HBO LatAm and Ocado. The UK start-up will use the funds raised to expand its leadership and sales teams, launch in the US market and continue to evolve its technology by enhancing its in-platform machine learning algorithms.